139 related articles for article (PubMed ID: 26989860)
1. Effects of short-chain acyl-CoA dehydrogenase on cardiomyocyte apoptosis.
Zeng Z; Huang Q; Shu Z; Liu P; Chen S; Pan X; Zang L; Zhou S
J Cell Mol Med; 2016 Jul; 20(7):1381-91. PubMed ID: 26989860
[TBL] [Abstract][Full Text] [Related]
2. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
3. Changes in short-chain acyl-coA dehydrogenase during rat cardiac development and stress.
Huang J; Xu L; Huang Q; Luo J; Liu P; Chen S; Yuan X; Lu Y; Wang P; Zhou S
J Cell Mol Med; 2015 Jul; 19(7):1672-88. PubMed ID: 25753319
[TBL] [Abstract][Full Text] [Related]
4. [Effects of short-chain acyl-CoA dehydrogenase on human umbilical vein endothelial cell apoptosis].
Li Z; Shu Z; Liao Y; Liu P; Lu J; Wang P; Wang G; Zang L; Zhou S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):756-761. PubMed ID: 31315737
[TBL] [Abstract][Full Text] [Related]
5. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
6. Flavine adenine dinucleotide inhibits pathological cardiac hypertrophy and fibrosis through activating short chain acyl-CoA dehydrogenase.
Ma Z; Qin X; Zhong X; Liao Y; Su Y; Liu X; Liu P; Lu J; Zhou S
Biochem Pharmacol; 2020 Aug; 178():114100. PubMed ID: 32540485
[TBL] [Abstract][Full Text] [Related]
7. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminoimidazole-4-carboxyamide-ribonucleoside (AICAR)-stimulated hepatic expression of Cyp4a10, Cyp4a14, Cyp4a31, and other peroxisome proliferator-activated receptor α-responsive mouse genes is AICAR 5'-monophosphate-dependent and AMP-activated protein kinase-independent.
Bumpus NN; Johnson EF
J Pharmacol Exp Ther; 2011 Dec; 339(3):886-95. PubMed ID: 21896918
[TBL] [Abstract][Full Text] [Related]
9. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.
Bronner M; Hertz R; Bar-Tana J
Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046
[TBL] [Abstract][Full Text] [Related]
10. Riboflavin protects against heart failure via SCAD-dependent DJ-1-Keap1-Nrf2 signalling pathway.
Xu Q; Cao Y; Zhong X; Qin X; Feng J; Peng H; Su Y; Ma Z; Zhou S
Br J Pharmacol; 2023 Dec; 180(23):3024-3044. PubMed ID: 37377111
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
12. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
13. [Change of short-chain acyl-CoA dehydrogenase in heart failure after myocardial infarction in rats and the intervention of aerobic exercise].
Liao Y; Li Z; Shu Z; Zhong X; Su Y; Ma Z; Liu P; Lu J; Zang L; Pan X; Zhou S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):172-177. PubMed ID: 30827304
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
Jen HL; Yin WH; Chen JW; Lin SJ
J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
[TBL] [Abstract][Full Text] [Related]
15. Riboflavin ameliorates pathological cardiac hypertrophy and fibrosis through the activation of short-chain acyl-CoA dehydrogenase.
Peng H; Xie M; Zhong X; Su Y; Qin X; Xu Q; Zhou S
Eur J Pharmacol; 2023 Sep; 954():175849. PubMed ID: 37331684
[TBL] [Abstract][Full Text] [Related]
16. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Kar D; Bandyopadhyay A
Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
[TBL] [Abstract][Full Text] [Related]
17. AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes.
Adrian L; Lenski M; Tödter K; Heeren J; Böhm M; Laufs U
Lipids; 2017 Sep; 52(9):737-750. PubMed ID: 28825205
[TBL] [Abstract][Full Text] [Related]
18. Short-chain acyl-CoA dehydrogenase is a potential target for the treatment of vascular remodelling.
Zhong X; Li Z; Xu Q; Peng H; Su Y; Le K; Shu Z; Liao Y; Ma Z; Pan X; Xu S; Zhou S
J Hypertens; 2023 May; 41(5):775-793. PubMed ID: 36883465
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
[TBL] [Abstract][Full Text] [Related]
20. Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes.
Pang T; Rajapurohitam V; Cook MA; Karmazyn M
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1382-90. PubMed ID: 20190100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
